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The present study. Gibbs et al. (I) report in this issue of 
the Journal on the use of a sophisticated micromanometer 
catheter system that permitted them to measure pulmonary 
artery pressure accurately and continuously over a 1 day 
period in nine patients with congestive heart failure. The 
subjects performed normal hospital activities, as well as four 
symptom-limited exercise stress tests: continuous free walk- 
ing on the level, continuous climbing up and down 18 stairs, 
and maximal exercise using both bicycle and treadmill 
protocols. The authors found that both symptoms and pul- 
monary artery pressure during maximal exercise were not 
the same as those recorded during normal activities. The rise 
in pulmonary artery pressure correlated with symptoms only 
during walking on the level. Of the four protocols, walking 
produced the least breathlessness and change in pulmonary 
artery pressure. The authors use these data to comment on 
the value of maximal exercise stress testing in patients with 
congestive heart failure, 
This is a provocative conclusion and leads to two ques- 
tions: 1) Do maximal stress tests have any place in the 
evaluation of the patient with congestive heart failure? 2) 
What relation does pulmonary artery pressure have to 
dyspnea in congestive heart failure? 
The role of maximal stress test in congestive heart failure. 
We would answer affirmatively to the first question, but with 
qualification. Conceptually, the maximal stress test can be 
defended as one of many measures of cardiovascular per- 
formance, and one of the few that gives one an index of 
overall integrated cardiocirculatory-pulmonary function. 
However, an index is just that-an index. None is perfect, 
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but, if useful, it is retaine . A distant analogy mig 
to automobile pet-forma e: maxima9 accelerati 
imal speed are never required im normal daily driving situa- 
tions. Both values dc give one an indication of how much 
distance between cars is required to enter a freeway safely or 
which lane should be used when ascending a steep axiom of 
a mountain highway. 
The maximal stress test ca 
of performance, to gauge dis 
monary reserve. This is an 
writing of a prescription for exercise co~ditioniR~ programs, 
many of which are now attracting patients with congestive 
heart failure. Although the maximal stress test is a good 
index, it is far from perfect. Often patients do not reach tbe 
plateau required to call the final attained level the maximum. 
Some investigators appropriately refer to this as the peak 
exercise level. In fact, it is possible that many patients 
cannot achieve a steady state as one progresses through 
submaximal levels as well. 
Although it was originally thought that the result of a 
maximal stress test would be an important measure 
prognosis, this promise has not been fully realized. Althoug 
oue can stratify patients according to maximal oxygen con- 
sumption (v02max) using a few different classification 
schemes, this variable is not continuous when plotted 
against probabihty of survival. Bf one uses a value of 
vO,max of IO ml~min-‘-kg-’ as a cutoff point, there is a 
decidedly poorer prognosis for those on the lower side (2). 
However, shifting the level up to just 13 creates two groups 
and mortality rates of these two groups are not significantly 
different (3). In this respect, VQmax behaves like plasma 
norepinephrine level;; a high value (above 600 pg/ml) is 
associated with a high risk, but the relation is dichotomous 
(4). 
Maximal exercise performance is perhaps best applied in 
evaluating the results of therapy. Mortality is not the only 
important end point in caring for the patien? with heart 
failure. It goes without saying that functional status rates 
high among therapeutic goals. However, because the syn- 
drome of heart failure itself waxes and wanes often over 
short periods of time, the stress test is better used to indicate 
a group effect, as in a clinical trial, than to follow the course 
of an individual patient. 
An appropriate qloesrion raised by Gibbs et al. (I) is the 
following: If a patient never exercises to maximum and daily 
activities are only a series of submaximal events, why bother 
with a maximal test? If one wants to know how difficul 
for Mr. Smith to go to the market and bring home a I 
bread, why not devise a test that measures that activity? 
This is not as easy as it sounds-testing endurance capacity 
at submaximal work loads has many pitfalls. If the work load 
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